Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Credit Suisse Group AG    CSGN   CH0012138530

CREDIT SUISSE GROUP AG

(CSGN)
  Report
Delayed Quote. Delayed Swiss Exchange - 07/16 09:56:53 am
10.15 CHF   -0.25%
08:36aCREDIT SUISSE : strengthens China securities joint venture with senior appointments
PU
07:45aENI : Credit Suisse remains Neutral
MD
06:59aASML : Credit Suisse remains its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Credit Suisse taps Santangelo as global co-head of healthcare

share with twitter share with LinkedIn share with facebook
06/29/2020 | 02:49pm EDT
An activist of environmental group Greenpeace is seen beside the logo of of Swiss bank Credit Suisse in Zurich

By Rebecca Spalding and Carl O'Donnell

Credit Suisse Group AG has named Rob Santangelo as a global co-head of its healthcare investment banking group, according to a memo seen by Reuters on Monday.

Santangelo, who is based in New York, will report to Robin Rankin, the Swiss bank's coverage and advisory head of global healthcare, retail and consumer products, and Latin America, the memo said. Santangelo will work alongside David Kostel, who remains a global co-head of the healthcare investment banking division.

Santangelo, who has been with Credit Suisse since 2007, was previously global head of equity capital markets (ECM) origination, and earlier in his career focused on the oil industry. Santangelo has also been named vice chairman of ECM to continue his coverage of certain energy clients, according to the memo.

A spokesperson for Credit Suisse confirmed the contents of the memo while declining to comment further.

Santangelo's appointment comes after Credit Suisse doubled the number of managing directors in its life science practice late last year in an effort to bulk up its expertise in healthcare.

(Reporting by Rebecca Spalding and Carl O'Donnell in New York; Editing by Sonya Hepinstall)

Stocks mentioned in the article
ChangeLast1st jan.
CREDIT SUISSE GROUP AG -0.20% 10.15 Delayed Quote.-22.36%
LONDON BRENT OIL -0.34% 43.46 Delayed Quote.-34.76%
WTI -0.40% 40.815 Delayed Quote.-34.03%
share with twitter share with LinkedIn share with facebook
Latest news on CREDIT SUISSE GROUP AG
08:36aCREDIT SUISSE : strengthens China securities joint venture with senior appointme..
PU
07:45aENI : Credit Suisse remains Neutral
MD
06:59aASML : Credit Suisse remains its Buy rating
MD
06:58aMICROSOFT CORP : Credit Suisse remains its Buy rating
MD
06:46aZALANDO : Receives a Buy rating from Credit Suisse
MD
01:39aHeineken says first-half revenue falls due to COVID-19, shares slide
RE
07/15AKZO NOBEL NV : Credit Suisse reiterates its Buy rating
MD
07/15JUST EAT TAKEAWAY.COM : Buy rating from Credit Suisse
MD
07/15GERRESHEIMER AG : Receives a Buy rating from Credit Suisse
MD
07/15ASML : Credit Suisse maintains a Buy rating
MD
More news
Financials
Sales 2020 20 859 M 22 054 M 22 054 M
Net income 2020 2 567 M 2 714 M 2 714 M
Net Debt 2020 - - -
P/E ratio 2020 9,56x
Yield 2020 2,46%
Capitalization 23 308 M 24 699 M 24 644 M
EV / Sales 2019
Capi. / Sales 2020 1,12x
Nbr of Employees 48 500
Free-Float 93,5%
Chart CREDIT SUISSE GROUP AG
Duration : Period :
Credit Suisse Group AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CREDIT SUISSE GROUP AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 11,67 CHF
Last Close Price 10,18 CHF
Spread / Highest target 67,1%
Spread / Average Target 14,7%
Spread / Lowest Target -40,3%
EPS Revisions
Managers
NameTitle
Thomas Gottstein Chief Executive Officer
Urs Rohner Chairman
James Walker Chief Operating Officer
David Richard Mathers Chief Financial Officer
John Ivan Tiner Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CREDIT SUISSE GROUP AG-22.36%24 699
JPMORGAN CHASE & CO.-28.46%303 937
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED-19.50%250 045
BANK OF AMERICA CORPORATION-30.15%213 420
CHINA CONSTRUCTION BANK CORPORATION-8.32%199 995
BANK OF CHINA LIMITED-16.82%133 316